BLUE
Bluebird bio Inc
-31.24%
$6.69 - $4.60
Feb 7th 2023 - Mar 21st 2023
Mar, 13, 2023
Large potential population of users 6. good/honest management 7.
Mar, 10, 2023
$BLUE great job motherfuccccing Bastard Management... See more
ACRX
Acelrx Pharmaceuticals Inc
-66.25%
$2.03 - $0.69
Feb 7th 2023 - Mar 21st 2023
Feb, 10, 2023
$ACRX Battlefield Pain Management Our new product... See more
Nov, 22, 2022
Our data confirm the safety and tolerability of SS... See more
FWBI
First Wave BioPharma Inc
-29.91%
$4.58 - $3.21
Feb 7th 2023 - Mar 21st 2023
Jan, 6, 2023
Three new board members- will energize the management.
Nov, 20, 2022
Emed will have a huge market for their devices and... See more
Mar, 13, 2023
Large potential population of users 6. good/honest management 7.
Mar, 10, 2023
$BLUE great job motherfuccccing Bastard Management 20 percent down for nothing ππΌππΌππΌππΌππΌππΌππΌππΌππΌππΌππΌππΌππΌππΌππΌππΌ
Mar, 9, 2023
Management comes through, delivers as promised. BOOM!
Mar, 5, 2023
silence from management is intriguing!
Mar, 1, 2023
Happy I sold at 8.3.. poor managment here , dont blame anybody else.
Feb, 24, 2023
And good management.
Feb, 9, 2023
managment f@#$ you all up.. π©π©π©
Jan, 19, 2023
Management is executing very well.
Jan, 18, 2023
I thought management was operating flawlessly,
Jan, 6, 2023
This company and management has been nothing short of amazing so far.ππΎ
Feb, 10, 2023
$ACRX Battlefield Pain Management Our new products meet these requirements and add to the pain-treatment options available to care providers.
Nov, 22, 2022
Our data confirm the safety and tolerability of SSTS in the management of postoperative pain, resulting in a high level of patient satisfaction and acceptance of pain control.
Nov, 3, 2022
This is a unique asset that we believe will have a profound positive impact on the management of acute pain within hospitals and other medically supervised settings," continued Mr. Rougemond.
Nov, 1, 2022
This is a unique asset that we believe will have a profound positive impact on the management of acute pain within hospitals and other medically supervised settings," continued Mr. Rougemond.
Oct, 27, 2022
This is a unique asset that we believe will have a profound positive impact on the management of acute pain within hospitals and other. .
Oct, 27, 2022
This is a unique asset that we believe will have a profound positive impact on the management of acute pain within hospitals and other medically supervised settings," continued Mr. Rougemond.
Jan, 6, 2023
Three new board members- will energize the management.
Nov, 20, 2022
Emed will have a huge market for their devices and imo will revolutionize the pain management industry.
Nov, 14, 2022
Management is experienced.
Nov, 7, 2022
$FWBI Great Management
Nov, 7, 2022
$FWBI Excellent Management
Nov, 7, 2022
$FWBI The management is good enough to get this stock into double digits.
Nov, 7, 2022
$FWBI Excellent Management
Nov, 7, 2022
$FWBI Educated and experienced management.
Nov, 7, 2022
$FWBI Great management.
Nov, 6, 2022
$FWBI Super Management π₯